INVESTIGATOR-INITIATED STUDIES

Endiatx is committed to advancing scientific and clinical understanding of its investigational technologies through company-sponsored research and investigator-initiated studies. This page is intended for qualified investigators seeking to propose independent research involving Endiatx investigational technologies.

PillVue, PillBot, Cortex, and related technologies described on this page are investigational devices under development and have not been cleared or approved by the U.S. Food and Drug Administration for commercial use.


INVESTIGATOR-INITIATED STUDIES

Endiatx welcomes proposals for investigator-initiated studies (IIS) involving our investigational technologies. These studies are independently developed and sponsored by the investigator or institution. Subject to applicable regulatory requirements and separate written agreement, Endiatx may provide limited support on a case-by-case basis, including investigational product access, technical information, training, or limited research funding.


CONDUCTING RESEARCH WITH PILLVUE

PillVue, our investigational capsule imaging platform being developed for stomach visualization, is currently the primary Endiatx technology available for independent research collaboration. Proposals may explore scientific, technical, workflow, usability, or clinical research questions involving investigational capsule imaging technologies.

To learn more about the platform, see our Technology page.


SUBMIT AN INQUIRY

To submit an inquiry, please email research@endiatx.com with:


REVIEW PROCESS

All proposals are reviewed based on scientific rationale, feasibility, available resources, and applicable regulatory, ethical, and institutional requirements. Submission of an inquiry does not guarantee support or participation by Endiatx.

Investigators are responsible for obtaining all required institutional, ethical, and regulatory approvals applicable to their proposed research. Any support provided by Endiatx is subject to separate written agreement and applicable regulatory requirements.